Skip to content

    Health X Platform Limited

    SASTASUNDR
    Healthcare·17 Nov 2025
    Management Summary

    Sastasundar Ventures Limited reported strong Q2 FY26 results with revenue growing 16.9% YoY to INR307.9 crores and gross profit up 34.2% YoY to INR22.9 crores, driven by robust performance in both RetailerShakti and Sastasundar B2C. Gross profit margin expanded by 100 bps to 7.5%. The company is well-capitalized with INR565 crores in treasury and aims for RetailerShakti to be EBITDA positive next quarter, while Sastasundar B2C targets profitability by FY28/29, supported by strategic expansion and AI-driven automation.

    Highlights

    5

    • Revenue from operations stood at INR307.9 crores, up 16.9% year-on-year and 10.6% quarter-on-quarter.

    • Gross profit was INR22.9 crores, up 34.2% year-on-year and 9.8% quarter-on-quarter.

    • Gross profit margin expanded by 100 basis points to 7.5% this quarter as compared to 6.5% in quarter 2 financial year '25.

    • Sastasundar B2C segment delivered around 60% year-on-year growth in Q2.

    • The company is fully capitalized with total treasury of INR565 crores and does not foresee a need for external capital for the next 5 years.

    Concerns

    2

    • Management expressed that they are 'not very much happy' with the current growth of Sastasundar B2C, aiming to reach INR500 crores annual run rate faster.

    • Acknowledged that building a large company with limited resources may lead to 'hiccups' or 'adjustments' at some point.

    What Changed2

    vs Q3 FY26

    Guidance items22 → 15 (-7)Risks discussed2 → 3 (+1)

    Key financials

    Single quarter

    03 metrics
    1. 01Revenue from Operations₹307.9 Cr+16.9%YoY
    2. 02Gross Profit₹22.9 Cr+34.2%YoY
    3. 03Gross Profit Margin7.5%

    Segment breakdown

    • RetailerShakti (B2B)₹267.8 Cr87.2%
    • Sastasundar (B2C)₹39.4 Cr12.8%
    Donut· Share of Revenue

    Capital allocation

    1
    high confidence
    CategoryHeadline
    Liquidity

    Cash ₹565 crores

    Total treasury in Sastasundar Healthbuddy Limited is INR445 crores and other fellow subsidiary companies is INR120 crores, totaling to INR565 crores. Net capital raise is INR222 crores. Management states the company is fully capitalized and does not need external capital for the next 5 years.

    Guidance & targets

    15
    CategoryTargetPriority
    Profitability
    RetailerShakti EBITDA
    EBITDA positive
    		High
    Profitability
    RetailerShakti EBITDA
    1% EBITDA positive
    		High
    Profitability
    Sastasundar B2C Contribution Margin
    margin positive
    		High
    Profitability
    Sastasundar B2C EBITDA
    EBITDA positive
    		Medium
    Profitability
    Total EBITDA Margin
    4-5%
    		Medium
    Revenue
    Sastasundar B2C Annual Run Rate
    INR500 crore
    		High
    Revenue
    Total Revenue
    INR6,000 crores
    		Medium
    Revenue
    Sastasundar B2C Revenue per HealthBuddy
    INR1 crore per year
    		High
    Retailers
    RetailerShakti Retailer Count
    55,000
    		High
    Growth
    RetailerShakti Compounding Growth
    >30%
    		High
    HealthBuddies
    Sastasundar B2C HealthBuddy Count
    360
    		High
    Working Capital
    Working Capital as % of Sales
    ~6%
    		High
    Working Capital
    Working Capital as % of Sales
    3-4%
    		Medium
    Product Rollout
    Retailer App Integration
    fully integrated
    		High
    Capital Needs
    External Capital Requirement
    None
    		High

    RetailerShakti EBITDA Positivity

    next quarter
    CurrentBreakeven
    TargetEBITDA positive

    Why it matters

    Achievement of EBITDA positivity for the B2B segment is a key step towards overall company profitability and validates the business model.

    For RetailerShakti, we are already running at a breakeven, and this breakeven will further be strengthened by next quarter. So next quarter, it will be EBITDA positive RetailerShakti segment-wise.

    How to verify

    key_financials.segment_breakdown[name='RetailerShakti (B2B)'].metrics[label='EBITDA']

    Risks & concerns

    3
    RiskSeverity

    Challenges of building a large company with limited resources

    Management noted that building a very large company with limited capital may lead to 'hiccups' or 'adjustments' in the growth trajectory. — Management acknowledged

    medium

    Customer adoption of new technology and apps

    Management stated that customer adoption of new apps and technology is a long-term process, requiring patience and sustained effort. — Management acknowledged

    low

    Complexity of reaching 140 crore Indians with healthcare solutions

    Management highlighted that reaching such a vast population with healthcare solutions will take significant time and requires simplification of processes. — Management acknowledged

    medium

    Q&A highlights

    8

    “For RetailerShakti, we are already running at a breakeven, and this breakeven will further be strengthened by next quarter. So next quarter, it will be EBITDA positive RetailerShakti segment-wise. And next year, we should be generating 1% EBITDA at RetailerShakti. ... Sastasundar we will be the margin positive company next year. ... So we can say in the year '28, '29 financial year, we should be EBITDA positive in Sastasundar.”

    Clarifies the specific timelines for both B2B and B2C segments to achieve EBITDA positive status, indicating a phased path to profitability.

    asked by Vivek Gupta

    2 min read5 chapters

    Detailed Narrative

    01

    Strong Q2 FY26 Performance and Margin Expansion

    Sastasundar Ventures Limited reported a robust Q2 FY26, with revenue from operations reaching INR307.9 crores, marking a 16.9% year-on-year and 10.6% quarter-on-quarter growth. Gross profit surged by 34.2% YoY to INR22.9 crores, leading to a 100 basis points expansion in gross profit margin to 7.5% from 6.5% in Q2 FY25. This performance reflects disciplined execution and steady momentum across both B2B and B2C segments.

    02

    Segmental Growth Drivers: RetailerShakti and Sastasundar B2C

    The core growth engines, RetailerShakti (B2B) and Sastasundar (B2C), continued their strong trajectory. RetailerShakti contributed INR267.8 crores to Q2 revenue, growing approximately 13% YoY. Sastasundar B2C showed even more significant growth, with revenue of INR39.4 crores, up around 60% YoY. This growth is attributed to disciplined vendor sourcing, streamlined procurement, and automated fulfillment operations, enhancing order density and repeat engagement.

    03

    Path to Profitability and Long-term Revenue Targets

    Management outlined a clear path to profitability, expecting RetailerShakti to be EBITDA positive next quarter and achieve 1% EBITDA positive next year. Sastasundar B2C is targeted to be contribution margin positive next year and EBITDA positive by FY28/29. The company aims for an overall revenue of INR6,000 crores by FY29/30, with INR4,000 crores from RetailerShakti and INR2,000 crores from Sastasundar B2C, projecting a 4-5% overall EBITDA margin.

    04

    Strategic Expansion and Capital Efficiency

    Sastasundar plans to expand its RetailerShakti network by adding 15,000 retailers to reach 55,000 by next year-end, targeting >30% compounding growth for the next 2-3 years. Geographical expansion will cover Orissa, Bihar, Jharkhand, Chhattisgarh, and Northern India, supported by new warehouses in Lucknow and Udaipur. The company is fully capitalized with INR565 crores in treasury and does not anticipate needing external capital for the next 5 years, leveraging its capital-efficient platform model.

    05

    AI, Automation, and New Initiatives

    The company is heavily investing in AI and automation to reduce costs and enhance efficiency. This includes automating warehouse operations (tripling capacity with minimal capital), reducing call center manpower by half, and AI coding. A new retailer app is in beta phase for April 2026 rollout, aiming for full integration by May/June 2026. The JITO brand, launched two months prior, is generating INR20 lakhs per month in orders, targeting the 100 crore Indian population outside the traditional medicine net with affordable healthcare solutions.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.